Amphastar Pharma (NASDAQ: AMPH) reported Q4 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $89.7 million versus the consensus estimate of $78.18 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.